Healthcare · NSE: KIMS
Krishna Institute of Medical Sciences
Q2 FY27 earnings call · Guided by management
Call held 5 Nov 2026 · Read the filing on NSEFiling
- M.Cap
- ₹30,547Cr
- P/E
- 143.8×
- 1Y return
- +5.81%
- From 52W high
- −15.2%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 1,344 | 961 | +39.9% | 1,180 | +14.0% |
| EBITDA | 260 | 204 | +27.6% | 223 | +16.5% |
| EBITDA margin | 19.4% | 21.2% | -187 bps | 18.9% | +42 bps |
| One-off items | 13 | -0 | — | — | — |
| PBTProfit before tax | 106 | 97 | +9.4% | 56 | +90.5% |
| Net profit | 75 | 67 | +11.8% | 42 | +80.7% |
| EPS (₹) | 1.79 | 1.67 | +7.2% | 1.04 | +72.1% |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.
Guidance
Electronic City: Electronic City quarterly break-even expected in Q4 rather than Q3
Abhinay Bollineni · Q&A · p. 9
Electronic City: Electronic City quarterly break-even expected in Q4 rather than Q3
“I think it's safe to assume Q4 rather than Q3, though we've seen the month of September break-even.”
Q2 called the bottom for margins, trajectory expected upward
Abhinay Bollineni · Q&A · p. 10
Q2 called the bottom for margins, trajectory expected upward
“But I think, yes, this is the bottom Q2 number. I think from here, the trajectory should be upward.”
More figures from the call
“We have doubled the capacity of our KIMS Saveera Hospital, Anantapur, from 250 to 500 beds.”
“Yes, 70% on 500 odd beds, we are at that occupancy.”
“We have a potential to add another 200, 250 beds and take it to a full capacity of 1,250 beds.”
“Beyond this, over the next 24 months, we are not looking at any significant bed addition, maybe on the lower side, around 400- 500 beds.”
“In Secunderabad, the capacity is 1,000, but what we have operational is only 700 beds.”
“First phase, we will only get the 250 beds that are not operational today operational because they are under renovation.”
In short
- 01Q2 FY27 total revenue was Rs 1,363 crore, up 41.3% year on year; EBITDA was Rs 279 crore, up 34%.
- 02Management said Q2 was the bottom for margins and the trajectory should be upward from here.
- 03New Kondapur hospital is at about 70% occupancy on 500 beds; margin expected back to about 30% in three to four quarters.
- 04Capex outflow of about Rs 1,100 crore expected over the next 18 months on Secunderabad, Rajahmundry and Kondapur.
- 05Net debt is Rs 2,150 crore with net debt to EBITDA of about 1.9.
- 06Acquired 51% of Sarvottam Health Care (Trust Hospital, Kakinada) for Rs 80 crore; signed O&M deals for Arete (Hyderabad) and Westfort (Thrissur).
- 07Andhra Pradesh margins hit by two new oncology programmes and a Rs 8 crore doubtful-debt provision on government dues.
- 08Electronic City hospital quarterly break-even expected in Q4 rather than Q3.
Capex
Secunderabad: New oncology hospital being built, to be commissioned end of next year
Abhinay Bollineni · Q&A · p. 11
Secunderabad: New oncology hospital being built, to be commissioned end of next year
“we also acquired a lot of clinical talent for our oncology hospital, which we are going to commission the end of next year, which is a new hospital that we are building.”
Secunderabad: Secunderabad building structure ready in next two months
Abhinay Bollineni · Q&A · p. 11
Secunderabad: Secunderabad building structure ready in next two months
“In the next two months, the building, the structure will be ready, and then we will keep doing the interiors as and when our requirements are.”
Next expansion phase from 2029-2030, mostly in existing states
Abhinay Bollineni · Q&A · p. 19
Next expansion phase from 2029-2030, mostly in existing states
“Yes, 2029, 2030 onwards. Then there is more expansion that we want to do in Andhra, Telangana, Karnataka, Kerala, and Tamil Nadu.”
Focus on stabilising operations before next expansion phase
Abhinay Bollineni · Q&A · p. 18
Focus on stabilising operations before next expansion phase
“The idea is to stabilize the operations here and then be ready for the next phase of expansion and capex outflow.”
Expansion over next four to five years to be in states already operated in
Abhinay Bollineni · Q&A · p. 19
Expansion over next four to five years to be in states already operated in
“It is largely in the states that we are already operating, except for Chennai. Whatever expansion we see over the next four to five years is going to come from the states that we are already operating in.”
Capacity
Kondapur: Remaining Kondapur beds to be commissioned in the next two quarters, earlier than planned
Abhinay Bollineni · Q&A · p. 8
Kondapur: Remaining Kondapur beds to be commissioned in the next two quarters, earlier than planned
“In the next quarter, we actually thought of commissioning the remaining beds next year, but we're going to commission the beds in the next two quarters.”
Maharashtra: Maharashtra: about 75 beds at Thane and 150 at Nashik not yet operational
Abhinay Bollineni · Q&A · p. 7
Maharashtra: Maharashtra: about 75 beds at Thane and 150 at Nashik not yet operational
“Thane also we have around 75 beds that are not operational, and Nashik we have close to 150 odd beds that are not operational.”
Old Kondapur hospital: Old Kondapur hospital beds empty, use not yet decided
Abhinay Bollineni · Q&A · p. 12
Old Kondapur hospital: Old Kondapur hospital beds empty, use not yet decided
“Yes, they are empty. We are yet to decide what we want to do with those beds.”
Rajahmundry; Ongole: Rajahmundry and Ongole expansions to be commissioned in four to five months
Abhinay Bollineni · Q&A · p. 18
Rajahmundry; Ongole: Rajahmundry and Ongole expansions to be commissioned in four to five months
“we have Rajahmundry and Ongole expansion that is going on, both of which will get commissioned in the next four to five months.”
Segments
Telangana: Telangana revenue rose from Rs 623 crore to Rs 700 crore quarter on quarter, led by Kondapur and Secunderabad
Abhinay Bollineni · Q&A · p. 6
Telangana: Telangana revenue rose from Rs 623 crore to Rs 700 crore quarter on quarter, led by Kondapur and Secunderabad
“Karan, I think the quarter-on-quarter growth from INR623 crores, we moved to INR700 crores. A large chunk of that revenue growth has come from Kondapur and Secunderabad unit.”
Kondapur: Kondapur revenue grew at least 70% in three months after move to new facility
Abhinay Bollineni · Q&A · p. 6
Kondapur: Kondapur revenue grew at least 70% in three months after move to new facility
“From what we moved to the old facility to the new facility, the revenue has grown by at least 70% in just three months.”
Vizag: Vizag back to 28%-29% margins by end of October after onco launch
Abhinay Bollineni · Q&A · p. 8
Vizag: Vizag back to 28%-29% margins by end of October after onco launch
“Actually, one of the hospitals where we launched the onco, which is Vizag, actually towards the end of October, we have seen it come back to 28%, 29% kind of margins.”
Anantapur: Anantapur to take at least a year to reach healthy margins
1yearAbhinay Bollineni · Q&A · p. 8
Anantapur: Anantapur to take at least a year to reach healthy margins
1year“So that will take at least a year before it comes back to healthy margins.”
Nashik: Nashik gets GIPSA empanelment, usually 40%-50% of insurance volume
Abhinay Bollineni · Q&A · p. 10
Nashik: Nashik gets GIPSA empanelment, usually 40%-50% of insurance volume
“Officially, we will be able to take patients from tomorrow in Nashik on GIPSA. That is a big chunk, that is usually 40%-50% of the overall insurance volume, which we got confirmation letter just last week.”
Demand
Inpatient volumes 81,668, up 27% year on year
Bhaskar Rao Bollineni · p. 4
Inpatient volumes 81,668, up 27% year on year
“The IP volumes 81,668 grew 27% year-on-year and 12.7% quarter-on-quarter.”
Outpatient volumes 731,010, up 23.3% year on year
Bhaskar Rao Bollineni · p. 4
Outpatient volumes 731,010, up 23.3% year on year
“The OP volumes, 731,010 grew 23.3% year-on-year and 11% quarter-on-quarter basis.”
Margins and costs
Q2 FY27 EBITDA margin 20.5% versus 20.1% in Q1 FY27
Bhaskar Rao Bollineni · p. 3
Q2 FY27 EBITDA margin 20.5% versus 20.1% in Q1 FY27
“EBITDA margin stood at 20.5% versus 20.1% in quarter one FY 2027”
Kondapur: New Kondapur unit has no losses but higher fixed cost
Abhinay Bollineni · Q&A · p. 6
Kondapur: New Kondapur unit has no losses but higher fixed cost
“There is no losses, fortunately, but the fixed cost has gone up, and as the revenue ramps up further, it will go back to the stable EBITDA margins.”
Andhra Pradesh: Two new oncology programmes at Vizag and Anantapur dragged Andhra Pradesh margins
Abhinay Bollineni · Q&A · p. 7
Andhra Pradesh: Two new oncology programmes at Vizag and Anantapur dragged Andhra Pradesh margins
“we have launched two large onco programs in two of our hospitals, one in Vizag and one in Anantapur. Because of which there is some drag on margin, that is one part.”
Old Kondapur hospital: Old Kondapur hospital costs Rs 1.5 crore a month for four to five more months
Abhinay Bollineni · Q&A · p. 15
Old Kondapur hospital: Old Kondapur hospital costs Rs 1.5 crore a month for four to five more months
“We are incurring a fixed cost of INR1.5 crores a month for the old hospital, and that includes the rental costs. That should continue for the next maybe four to five months”
New hospitals move from break-even to high single digit, mid-teens, then 20%+ margins
Abhinay Bollineni · Q&A · p. 12
New hospitals move from break-even to high single digit, mid-teens, then 20%+ margins
“First, we become EBITDA break-even, then we get to a high single digit, then get to a mid-teens, and then the 20%+ kind of margins start coming in.”
Debt and working capital
Cash and equivalents of Rs 420 crore as on 30 September 2026
Bhaskar Rao Bollineni · p. 3
Cash and equivalents of Rs 420 crore as on 30 September 2026
“Cash and cash equivalents, including cash, bank balance, deposits with maturity of less than 12 months, and investment in mutual funds of INR420 crores as on 30th September 2026.”
Andhra Pradesh: Doubtful-debt provision of Rs 7.8 crore on government dues this quarter
Sachin Salvi · Q&A · p. 8
Andhra Pradesh: Doubtful-debt provision of Rs 7.8 crore on government dues this quarter
“For the current quarter, we have provided INR7.5 crores, INR7.8 crores to be exact, towards provision for doubtful debts.”
Andhra Pradesh: Received over Rs 70 crore from AP government last quarter
Sachin Salvi · Q&A · p. 8
Andhra Pradesh: Received over Rs 70 crore from AP government last quarter
“In fact, in the last quarter, if you recollect, already we have received some INR70+ crores from the AP government.”
Project debt for Kondapur, Secunderabad and Rajahmundry already tied up, drawn as needed
Sachin Salvi · Q&A · p. 16
Project debt for Kondapur, Secunderabad and Rajahmundry already tied up, drawn as needed
“For completing these projects, already the debts were tied up. So as and when we require to spend the capital on it, we are raising that debt and we are paying the capex.”
Net debt Rs 2,150 crore; net debt to EBITDA about 1.9
Sachin Salvi · Q&A · p. 18
Net debt Rs 2,150 crore; net debt to EBITDA about 1.9
“Yes, INR2,150 to be exact is the net debt, and net debt to EBITDA ratio will be about 1.9 odd.”
Fund raising
25% of QIP and warrant proceeds set for general corporate purposes
Sachin Salvi · Q&A · p. 16
25% of QIP and warrant proceeds set for general corporate purposes
“we have allocated 25% of the total proceeds which we are receiving towards general corporate purposes.”
QIP general-purpose money parked; for loss funding, small and minority acquisitions
Sachin Salvi · Q&A · p. 16
QIP general-purpose money parked; for loss funding, small and minority acquisitions
“We have parked it in the mutual funds or in the bank account as of now. The money is to be used for general corporate purposes, which includes loss funding, which includes small acquisitions, which includes minority acquisition, as and when we decide to do so.”
Acquisitions and new business
KIMS Trust Hospital, Kakinada: Acquired 51% of Sarvottam Health Care (Trust Hospital, Kakinada, 183 beds) for Rs 80 crore
Bhaskar Rao Bollineni · p. 4
KIMS Trust Hospital, Kakinada: Acquired 51% of Sarvottam Health Care (Trust Hospital, Kakinada, 183 beds) for Rs 80 crore
“KIMS Trust Hospital, Kakinada, 183 beds, we have acquired 51% of equity stake in Sarvottam Health Care Private Limited. That is Trust Hospital by investing INR80 crores.”
Ushahkal Abhinav Specialty Hospital, Sangli: Acquired 6% stake in Ushahkal Abhinav Specialty Hospital, Sangli, for Rs 15 crore
Bhaskar Rao Bollineni · p. 4
Ushahkal Abhinav Specialty Hospital, Sangli: Acquired 6% stake in Ushahkal Abhinav Specialty Hospital, Sangli, for Rs 15 crore
“Ushahkal Abhinav Specialty Hospital, Sangli, Maharashtra, with 316 beds. We have acquired 6% stake by investing INR15 crores.”
KIMS Kompally; KIMS Sikhara Guntur: KIMS Kompally and KIMS Sikhara Guntur acquisitions to be made over time as internal resources allow
Bhaskar Rao Bollineni · p. 4
KIMS Kompally; KIMS Sikhara Guntur: KIMS Kompally and KIMS Sikhara Guntur acquisitions to be made over time as internal resources allow
“The above two acquisitions i.e KIMS Kompally and KIMS Sikhara Guntur will be made over a period of time whenever our internal resources are comfortable.”
Arete Hospitals, Gachibowli: O&M agreement signed with 300-bed Arete Hospitals, Gachibowli, Hyderabad
Bhaskar Rao Bollineni · p. 4
Arete Hospitals, Gachibowli: O&M agreement signed with 300-bed Arete Hospitals, Gachibowli, Hyderabad
“We have entered into an O&M agreement with the Arete Hospitals in Gachibowli, Hyderabad, which has a bed capacity of 300 beds.”
Westfort Hospital, Thrissur: O&M agreement signed with 300-bed Westfort Hospital, Thrissur, Kerala
Bhaskar Rao Bollineni · p. 4
Westfort Hospital, Thrissur: O&M agreement signed with 300-bed Westfort Hospital, Thrissur, Kerala
“We also entered into O&M agreement with Westfort Hospital in Thrissur, Kerala. It is an established and reputed hospital with a 300-bed capacity.”
One-offs
O&M hospitals: Call option fair value gain of Rs 13.2 crore booked below EBITDA
Sachin Salvi · Q&A · p. 15
O&M hospitals: Call option fair value gain of Rs 13.2 crore booked below EBITDA
“And in fact, in the current quarter also, the fair value of the call option is enhanced by INR13.2 crores, which we have accounted below EBITDA.”
Andhra Pradesh: Provision expected to reverse in next one or two quarters once money is received
Sachin Salvi · Q&A · p. 8
Andhra Pradesh: Provision expected to reverse in next one or two quarters once money is received
“I think in the next quarter or the next to next quarter, once the money is received, the same provision which we have done will get reversed.”
Risks
Oncology: Anti-cancer drug trade margin cap impact may not be significant, details due 9 November
Abhinay Bollineni · Q&A · p. 6
Oncology: Anti-cancer drug trade margin cap impact may not be significant, details due 9 November
“Right now, because oncology is not a big part of our revenue stream, the impact may not be significant.”
Thane; Mahadevapura: Thane and Mahadevapura still lack empanelment with some major insurers
Abhinay Bollineni · Q&A · p. 9
Thane; Mahadevapura: Thane and Mahadevapura still lack empanelment with some major insurers
“We are yet to get GIPSA, Star, and some other insurance companies, in spite of which both these hospitals have ramped up and broken even.”
Kerala: Impact of proposed Kerala hospital-charge regulation cannot yet be judged
Abhinay Bollineni · Q&A · p. 19
Kerala: Impact of proposed Kerala hospital-charge regulation cannot yet be judged
“No, we have no idea what they are going to do, Rahul. Unless we know what it is, what kind of impact, it's difficult to anticipate that today.”
Thane; Mahadevapura; Electronic City: Remaining insurance empanelments expected to complete towards end of the year
Abhinay Bollineni · Q&A · p. 9
Thane; Mahadevapura; Electronic City: Remaining insurance empanelments expected to complete towards end of the year
“And the fight for insurance empanelment will still continue for some more time. Maybe towards the end of the year, all the other smaller companies and some major companies and some of the hospitals should be completed.”
Other
Q2 FY27 total revenue Rs 1,363 crore, up 41.3% year on year
Bhaskar Rao Bollineni · p. 3
Q2 FY27 total revenue Rs 1,363 crore, up 41.3% year on year
“Total revenue of INR1,363 crores, a growth of 41.3% on year-on-year”
Q2 FY27 EBITDA Rs 279 crore, up 34% year on year
Bhaskar Rao Bollineni · p. 3
Q2 FY27 EBITDA Rs 279 crore, up 34% year on year
“EBITDA of INR279 crores, a growth of 34% on year-on-year”
Q2 FY27 PAT Rs 76 crore against Rs 37 crore in Q1 FY27 and Rs 72 crore in Q2 FY26
Bhaskar Rao Bollineni · p. 3
Q2 FY27 PAT Rs 76 crore against Rs 37 crore in Q1 FY27 and Rs 72 crore in Q2 FY26
“PAT at INR76 crores in quarter two, financial year 2027, against INR37 crores and INR72 crores in quarter one FY 2027 and quarter two FY 2026, respectively.”
Cooperation agreement with NHS University Hospitals of Liverpool
Bhaskar Rao Bollineni · p. 5
Cooperation agreement with NHS University Hospitals of Liverpool
“In this connection, I am happy to share that KIMS and NHS University Hospitals of Liverpool have advanced an agreement for cooperation in research, clinical collaboration, education, and training.”
Transplants: Liver transplants in five hospitals; kidney transplants in almost all units
Abhinay Bollineni · Q&A · p. 10
Transplants: Liver transplants in five hospitals; kidney transplants in almost all units
“The kidney transplant we offer in almost all the units except for one or two. Liver transplant, we do them in five of the hospitals.”
Sources
- Earnings call transcript, Q2 FY27 Filed 11 Nov 2026 · 19 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

